By Tess Stynes The Wall Street Journal Biography @TessStynes [email protected] July 29, 2015 4:42 p.m. ET Vertex Pharmaceuticals Inc. said its second-quarter revenue rose 20% on strong sales of […]
Veeva CRM’s native support for Windows 10 provides single-device choice for life sciences companies PLEASANTON, CA – July 29, 2015 – Veeva Systems’ latest release of Veeva CRM Mobile this […]
Gilead Sciences Inc. said its two key hepatitis C drugs, Sovaldi and Harvoni, generated about $4.9 billion in sales in the second quarter, topping Wall Street estimates, thanks to better-than-expected […]
I know by now news on coffee research is a little hard to swallow, considering how often new studies come out with contradictory conclusions. But don’t give up on coffee […]
SHYFT Analytics Delivers Transformational Insights to Life Sciences With Next Generation Real World Evidence Analytics Platform WALTHAM, MA–(Marketwired – Jul 29, 2015) – SHYFT Analytics, a leader in cloud-based data […]
Many of the drugs that are sold over-the-counter (OTC) began life as prescription medications. Anti-ulcer/heartburn drugs such as the histamine H2 antagonist, Zantac, and the proton-pump inhibitor, Prilosec, were first […]
What do you get when you combine Obamacare with an expected explosion in the use of pricey drugs and the rapid aging of the Baby Boomer population? The answer, courtesy […]
Twenty-seven years ago George Yancopoulos was a scientific superstar, a professor of biology at Columbia at age 28. But his father, a first-generation Greek immigrant, kept complaining about how little […]
Teva Pharmaceutical Industries may have found the deal it wanted in purchasing Allergan’s generics business for $40.5 billion in cash and stock, but the Israeli pharmaceutical company stands to lose around $300 […]
At age 45, Allergan Chief Executive Brent Saunders already pulled off something like $150 billion worth of deals. Now he’s going to get ready to do it again. Last year alone Saunders […]
